Eckert & Ziegler Strahlen- und Medizintechnik Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Eckert & Ziegler Strahlen- und Medizintechnik Stock Forecast and Price Target
If the average price target of 60.00€ set by distinguished experts for Eckert & Ziegler Strahlen- und Medizintechnik over the past few weeks is reached this year, there would be a potential upside of approximately 78.15% from the last closing price in April, 2024. This potential increase is based on a high estimate of 60.00€ and a low estimate of 60.00€. Even if you are not interested in EUZ stock, it is still imperative to be aware of its competitors.
78.15% Upside
Eckert & Ziegler Strahlen- und Medizintechnik Fair Value Forecast for 2023 - 2025 - 2030
Eckert & Ziegler Strahlen- und Medizintechnik's Price has decreased by 100.00% In the last four years, from 73.03€ to 0.00€. For next year, analysts predict Fair Value of 98.69€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Eckert & Ziegler Strahlen- und Medizintechnik's Fair Value will grow at a rate of 100.00%.
Eckert & Ziegler Strahlen- und Medizintechnik Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Eckert & Ziegler Strahlen- und Medizintechnik's Revenue has grown by 26.18%, rising from 176.14€M to 222.26€M. For next year, analysts predict Revenue of 261.20€M, which would mean an increase of 17.52%. Over the next seven years, experts predict that Eckert & Ziegler Strahlen- und Medizintechnik's Revenue will grow at a rate of 30.45%.
Eckert & Ziegler Strahlen- und Medizintechnik Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Eckert & Ziegler Strahlen- und Medizintechnik's Dividend per Share has grown, rising from 0.45€ to 0.50€ – a growth of 11.11%. The next year, 1 experts forecast that Eckert & Ziegler Strahlen- und Medizintechnik's Dividend per Share will decrease by 0.00%, reaching 0.50€. For the next seven years, the forecast is for Dividend per Share to grow by 19.14%.
Eckert & Ziegler Strahlen- und Medizintechnik EBITDA Forecast for 2023 - 2025 - 2030
Eckert & Ziegler Strahlen- und Medizintechnik's EBITDA has seen impressive growth In the last two years, rising from 42.92€M to 48.40€M – a growth of 12.77%. In the next year, analysts believe that EBITDA will reach 61.80€M – an increase of 27.69%. For the next seven years, the forecast is for EBITDA to grow by 48.40%.
Eckert & Ziegler Strahlen- und Medizintechnik EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Eckert & Ziegler Strahlen- und Medizintechnik's EBIT has grown by 13.73%, rising from 35.98€M to 40.92€M. For the next year, analysts predict that EBIT will reach 48.20€M – an increase of 17.79%. Over the next seven years, experts believe that Eckert & Ziegler Strahlen- und Medizintechnik's EBIT will grow at a rate of 36.44%.
Eckert & Ziegler Strahlen- und Medizintechnik EPS Price Prediction Forecast for 2023 - 2025 - 2030
Eckert & Ziegler Strahlen- und Medizintechnik's EPS has decreased by 100.00% In the last four years, from 1.11€ to 0.00€. For next year, analysts predict EPS of 1.50€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Eckert & Ziegler Strahlen- und Medizintechnik's EPS will grow at a rate of 100.00%.